Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X about a paper by Minesh P. Mehta et al. published in the International Journal of Radiation Oncology, Biology, Physics:
“Final results from phase III METIS trial of TTFields after SRS for brain metastases from NSCLC in the International Journal of Radiation Oncology, Biology, Physics. Adding TTFields delayed time to intracranial progression after SRS vs SRS alone: HR 0.72 (0.63 with IO), 2y intracranial progression rate 54% vs 65%.”
Title: Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study
Authors: Minesh P. Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, David Roberge, Terence Tai Weng Sio, Daniel M. Trifiletti, Thierry Muanza, Ana Misir Krpan, Zhengfei Zhu, Naren R Ramakrishna, John B. Fiveash, Philippe Metellus, Jinming Yu, Chiachien Jake Wang, Julian Jacob, Christian F. Freyschlag, Tibor Csőszi, Andrea Salmaggi, Alisa Taliansky, Ana Lucas, Jürgen Debus, Paul D. Brown, and Maciej Harat
You can read the Full Article in the International Journal of Radiation Oncology, Biology, Physics.
More posts featuring Stephen V Liu.